CDSCO expert panel to review vaccine applications today

69
CDSCO FDA

NEW DELHI : An expert committee of the Central Drugs Standard Control Organisation (CDSCO) will meet today to review applications of PfizerSerum Institute of India and Bharat Biotech seeking emergency use authorisation for their C-19 vaccine candidates, official sources said.

The decision was taken late on Monday evening after the Hyderabad-based Bharat Biotech became the third pharmaceutical firm to apply to the Drugs Controller General of India (DCGI) for emergency use authorisation for its indigenously developed C-19 vaccine Covaxin.

The Indian arm of US pharmaceutical giant Pfizer had on December 4 sought approval for its vaccine from the central drug regulator, after the firm secured such clearance in the UK and Bahrain.


Also read | DPCO-Amendment Order 2019: What Industry says


The Pune-based Serum Institute of India sought such a nod for the Oxford C-19 vaccine, Covishield, on December 6.

DCGI has already started processing the applications. The subject expert committee on C-19 at CDSCO will deliberate on the applications by Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorisation for their C-19 vaccines on December 9,” a source said.

At an all-party meeting on December 4, Prime Minister Narendra Modi had expressed hope that a C-19 vaccine may be ready in a few weeks.


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.